会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • NOVEL SUSTAINED RELEASE DOSAGE FORMS
    • 新的持续释放剂型
    • US20150057358A1
    • 2015-02-26
    • US14390046
    • 2013-04-08
    • Dow Global Technologies LLC
    • Meinolf BrackhagenRoland AddenOliver PetermannRobert L. SammlerDavid E. Wallick
    • A61K31/167A61K9/20
    • A61K31/167A61K9/2018A61K9/2054A61K9/2095C08B11/08C08B11/193C08L1/284
    • A sustained release dosage form comprises an active ingredient blended with a polymeric matrix. At least a portion of the polymeric matrix is formed by a cellulose ether having an onset dissolution temperature of at least 40° C., having anhydroglucose units joined by 1-4 linkages and having methyl groups, hydroxyalkyl groups, and optionally alkyl groups being different from methyl as substituents such that the cellulose ether has an MS (hydroxyalkyl) of 0.05 to 1.00, and hydroxyl groups of anhydrogluclose units are substituted with methyl groups such that [s23/s26−0.2*MS(hydroxyalkyl)] is 0.31 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxyl groups in the 2- and 3-positions of the anhydroglucose unit are substituted with a methyl group and wherein s26 is the molar fraction of anhydroglucose units wherein only the two hydroxyl groups in the 2- and 6-positions of the anhydroglucose unit are substituted with a methyl group.
    • 持续释放剂型包含与聚合物基质共混的活性成分。 聚合物基质的至少一部分由起始溶解温度为至少40℃的纤维素醚形成,其具有通过1-4键连接且具有甲基,羟基烷基和任选的烷基不同的脱水葡萄糖单元 由甲基作为取代基,使得纤维素醚具有0.05至1.00的MS(羟基烷基),并且脱甲羟基化单元的羟基被甲基取代,使得[s23 / s26-0.2 * MS(羟烷基)]为0.31以下, 其中s23是脱水葡萄糖单元的摩尔分数,其中只有脱水葡萄糖单元的2-和3-位上的两个羟基被甲基取代,并且其中s26是脱水葡萄糖单元的摩尔分数,其中只有两个羟基在 脱水葡萄糖单元的2-位和6-位被甲基取代。